Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1988 Oct;65(2):187–191.

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

K C McCullough 1, D Parkinson 1, J R Crowther 1
PMCID: PMC1384912  PMID: 2847979

Abstract

Using isolated peritoneal adherent cells, in which monocytes and macrophages dominate, the uptake and destruction of foot-and-mouth disease virus (FMDV) was enhanced by the opsonization with mAb of particular epitope specificity. This was seen under conditions in which virus infectivity was not neutralized, as determined by in vitro assay. Activation of macrophages in vivo further enhanced the uptake of opsonized virus, presumably by increasing the percentage of phagocytosing cells. The enhanced phagocytosis required opsonization and apparently made use of FcR+ cells, because pepsin-treated antibodies and separated F(ab')2 fragments did not enhance the capacity of the peritoneal cells to react with the virus. The reaction also relied on active phagocytosis, because inhibition of phagocytosis using silica interfered with the binding of both virus alone and virus/antibody complexes. This evidence shows that the previous in vivo observations (McCullough et al., 1986b) of enhanced protection by the mAb can be related to active phagocytosis of virus and virus/antibody complexes. The reaction is not passive adsorption to the monocyte surface, but an active phagocytosis of the virus or the complex.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN F., CARTWRIGHT B. PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS. Nature. 1963 Sep 21;199:1168–1170. doi: 10.1038/1991168a0. [DOI] [PubMed] [Google Scholar]
  2. Hamblin C., Barnett I. T., Crowther J. R. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods. 1986 Oct 23;93(1):123–129. doi: 10.1016/0022-1759(86)90442-4. [DOI] [PubMed] [Google Scholar]
  3. MACKOWIAK C., LANG R., FONTAINE J., CAMAND R., PETERMANN H. G. [Relation between the titer of neutralizing antibodies and the protection of animals following anti-aphthous vaccination]. Ann Inst Pasteur (Paris) 1962 Aug;103:252–261. [PubMed] [Google Scholar]
  4. McCullough K. C., Butcher R. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol. 1982;74(1):1–9. doi: 10.1007/BF01320777. [DOI] [PubMed] [Google Scholar]
  5. McCullough K. C., Crowther J. R., Butcher R. N. A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods. 1985 Aug;11(4):329–338. doi: 10.1016/0166-0934(85)90026-6. [DOI] [PubMed] [Google Scholar]
  6. McCullough K. C., Crowther J. R., Butcher R. N., Carpenter W. C., Brocchi E., Capucci L., De Simone F. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology. 1986 Jul;58(3):421–428. [PMC free article] [PubMed] [Google Scholar]
  7. McCullough K. C., Crowther J. R., Carpenter W. C., Brocchi E., Capucci L., De Simone F., Xie Q., McCahon D. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology. 1987 Apr;157(2):516–525. doi: 10.1016/0042-6822(87)90294-7. [DOI] [PubMed] [Google Scholar]
  8. Turner M. W., Bennich H. Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization. Biochem J. 1968 Mar;107(2):171–178. doi: 10.1042/bj1070171. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES